TACSTD2 and lung cancer: Bessede Bessede A A Peyraud Peyraud F F Besse Besse B B TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer Clin Cancer Res Clin Cancer Res 2024 2024 30 30 779 779 785 785 supplied-pmid 38048058?